Rep. Gilbert Ray Cisneros Jr. (D-CA) Buys HQY Stock

Democratic Representative Gilbert Ray Cisneros Jr. picked up shares of HealthEquity, Inc. (NasdaqGS: HQY) in a late June trade. According to a periodic transaction report filed under the STOCK Act with the House, the Democratic lawmaker disclosed a purchase valued between $1,001 and $15,000. The trade was executed on June 30, 2026, and disclosed to the public on July 2, 2026. Trade disclosures by members of Congress provide visibility into personal portfolio adjustments, though they reflect broad value ranges rather than exact share counts or dollar figures. This follows recent disclosures by the lawmaker covering several other public companies over the summer.

HQY HealthEquity, Inc.

$92.03 ▲ +1.05% year to date

1M 3M YTD

Daily close · Oct 16, 2026

Inside Rep. Gilbert Ray Cisneros Jr.'s HealthEquity Trade

The transaction took place on June 30, 2026, when HealthEquity closed at $90.32 per share. Because the STOCK Act permits reporting through tiered ranges rather than precise figures, the exact scale of the lawmaker's investment remains bounded between $1,001 and $15,000. Lawmakers frequently file these periodic transaction reports days after executing trades, offering a window into how elected officials allocate personal capital across various sectors.

Other Institutional Activity in HealthEquity

Other large institutional investors adjusted their positions in HealthEquity around the same period. Wasatch Advisors LP trimmed its holdings by 948,873 shares, ending the period with 7,011,469 shares valued at about $652,557,417. AQR Capital Management, LLC reduced its position by 93,108 shares, bringing its stake to 1,999,209 shares worth about $186,066,381. Meanwhile, William Blair Investment Management, LLC grew its holdings by 113,679 shares, ending with 1,773,227 shares valued at about $165,034,236.

HealthEquity, Inc. Stock Down 0.1%

HealthEquity shares recently traded around $91.94 as of October 16, 2026, sitting up about 1.8% from their June 30 closing price of $90.32. The stock trades about 4.2% below its 50-day moving average of $96.02 and about 3.8% above its 200-day moving average of $88.59. The company's shares remain roughly 14.6% below their 52-week high of $107.62 while holding 26.4% above their 52-week low of $72.76.

Recent Earnings

HealthEquity generated $1,362,123,008 in trailing-twelve-month revenue with earnings of $2.77 per share over the same period. The healthcare services provider posted a net margin of 17.4% and a return on equity of 11.4%. The company's next earnings report is scheduled for December 2, 2026.

Dividend

HealthEquity does not currently pay a dividend, maintaining a payout ratio of 0.0% and a dividend yield of 0.0%.

Insider Buying and Selling at HealthEquity, Inc.

Company insiders also transacted in HealthEquity shares prior to the lawmaker's trade. On May 28, 2026, General Counsel Delano W Ladd IV sold 7,500 shares at an average price of $90.00 for a total value of $675,000. On the same day, Director Gayle Furgurson Wellborn sold 2,439 shares at $90.00 for $219,510. Shortly after, on May 29, 2026, officer Michael Henry Fiore sold 3,142 shares at $95.00 for $298,490, followed by another sale of 2,470 shares at $95.00 valued at $234,650 on July 2, 2026.

Analysts Set New Price Targets

Wall Street firms have updated their outlooks on HealthEquity following recent financial reports. On July 24, 2026, BTIG maintained a Buy rating while lifting its price target from $110.00 to $115.00. BTIG later reiterated its Buy rating at $115.00 on August 28, 2026. Deutsche Bank maintained a Buy rating on August 31, 2026, raising its target from $135.00 to $142.00. Barclays maintained an Overweight rating on September 18, 2026, raising its target from $110.00 to $115.00. Across the broader analyst community, HealthEquity holds a consensus recommendation key of strong_buy with a mean price target of $119.33 based on 15 analyst opinions.

About HealthEquity

HealthEquity, Inc. builds technology-enabled service platforms that help consumers and employers manage healthcare savings and investments. Based in Draper, Utah, the company focuses on health savings accounts alongside online automated investment advisory tools. Its services support individuals navigating modern healthcare benefits and long-term medical planning.

Bottom Line

Congressional stock disclosures offer insight into the personal investments of elected officials without signaling broader economic trends or portfolio guidance. Observers can look toward HealthEquity's upcoming earnings release on December 2, 2026, for further operational updates from the company.